Institute of Pharmaceutical Technology, Faculty of Pharmacy, University "Ss Cyril and Methodius" , Vodnjanska 17, P.O. Box 36, 1000 Skopje , Macedonia.
J Microencapsul. 2013;30(7):643-56. doi: 10.3109/02652048.2013.770099. Epub 2013 Apr 2.
We have previously reported the development and characterisation of wheat germ agglutinin (WGA)-functionalised chitosan-Ca-alginate (CTS-Ca-ALG) microparticles (MPs) loaded with acid-resistant particles of 5-fluorouracil (5-FU). In the present work, our goal was to evaluate the potential of these carriers for efficient treatment of colon cancer by studying in vitro permeability and cell association of 5-FU and [methyl-³H]thymidine uptake in Caco-2 cells, as well as in vivo gastrointestinal distribution. The amount of 5-FU permeated through Caco-2 cells was 15.1, 7.7 and 6.5% for 5-FU solution, CTS-Ca-ALG MPs and WGA conjugates. The concentration of 5-FU associated with Caco-2 cells was significantly greater when delivered from MPs. By incorporation of 5-FU into MPs and further decoration with WGA, an increased [methyl-³H]thymidine uptake was observed few hours after continuous drug treatment followed by significantly reduced uptake after 6 h. Gastrointestinal distribution was in favour of increased localisation and concentration of the particles in colon region.
我们之前曾报道过小麦胚凝集素(WGA)功能化壳聚糖-海藻酸钙(CTS-Ca-ALG)载药微球(MPs)的开发和特性,这些 MPs 负载了耐酸的 5-氟尿嘧啶(5-FU)颗粒。在本研究中,我们的目的是通过研究 5-FU 和 [甲基-³H]胸苷摄取在 Caco-2 细胞中的体外通透性和细胞相关性,以及体内胃肠道分布,评估这些载体在治疗结肠癌方面的潜力。5-FU 溶液、CTS-Ca-ALG MPs 和 WGA 缀合物分别透过 Caco-2 细胞的 5-FU 量为 15.1%、7.7%和 6.5%。从 MPs 给药时,与 Caco-2 细胞结合的 5-FU 浓度显著更高。通过将 5-FU 掺入 MPs 并进一步用 WGA 修饰,在持续药物治疗数小时后观察到 [甲基-³H]胸苷摄取增加,6 小时后摄取显著减少。胃肠道分布有利于增加颗粒在结肠区域的定位和浓度。